Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Common Kidney Function Tests May Miss CKD in Cancer Patients

By LabMedica International staff writers
Posted on 26 Oct 2026

Chronic kidney disease (CKD) can complicate cancer care, as reduced kidney filtration may affect treatment eligibility and dosing. More...

In oncology, kidney function assessment often relies on estimated glomerular filtration rate rather than direct measurement, potentially leaving CKD unrecognized. This can create diagnostic uncertainty in patients receiving anticancer therapy. New findings highlight this limitation, showing that commonly used kidney function tests may miss CKD in adults with solid tumors.

University of São Paulo Medical School (FMUSP) researchers evaluated kidney function assessment in 1,200 adults with solid tumors. They compared measured glomerular filtration rate, which directly assesses kidney filtration using a specialized clearance marker, with estimated glomerular filtration rate values derived from the blood markers creatinine, cystatin C, or both.

CKD prevalence was 18.9% based on measured glomerular filtration rate, compared with 10.2% using creatinine-based estimates and 15.7% using estimates combining creatinine and cystatin C. This discrepancy was particularly evident among patients with measured filtration rates of 45–59 mL/min/1.73 m²: 72.1% had creatinine-based estimates above 60, potentially masking their reduced kidney function.

The discrepancy extended to patients with more advanced CKD. Among those with measured glomerular filtration rates below 45 mL/min/1.73 m², 52.5% had creatinine-based estimates above 45. Adding cystatin C to creatinine reduced the discrepancy between measured and estimated filtration rates, although concordance remained poor.

Presented at ASN Kidney Week 2026, held October 22–25, the findings highlight differences at thresholds relevant to drug eligibility and dose adjustment. Drug clearance often decreases as kidney function declines, making these assessments important for treatment decisions. Cisplatin dosing recommendations, for example, use glomerular filtration rate thresholds to guide dose reduction or determine treatment eligibility.

“The results suggest that errors in GFR estimation may contribute to excessive toxicity in patients with cancer receiving anticancer therapy,” said Veronica Torres Costa e Silva, M.D., Ph.D., corresponding author at the University of São Paulo Medical School.

Related Links
University of São Paulo Medical School
American Society of Nephrology


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Platelet Function Analyzer
PL-12
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Lung Cancer Atlas Reveals Cellular Patterns Associated With Patient Prognosis

Lung cancer is a leading cause of cancer-related death worldwide and is characterized by substantial cellular heterogeneity. Even within a single tumor, cancer cells can vary in aggressiveness, while immune,... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Malaria is caused by Plasmodium parasites, primarily transmitted through the bites of infected female Anopheles mosquitoes (Image Credit: Adobe Stock)

Complete Malaria Genomes Could Improve Species Identification and Surveillance

Malaria remains a major global health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. Although most research has focused on Plasmodium falciparum, Plasmodium ovale... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.